(Q34417562)

2 August 2017

1 reference

title

Exploiting genetic alterations to design novel therapies for cancer (English)

1 reference

2 August 2017

Cripe TP

1

1 reference

PubMed ID

11676278

2 August 2017

Mackall CL

series ordinal

2

1 reference

2 August 2017

1 August 2001

1 reference

Hematology / Oncology Clinics of North America

2 August 2017

1 reference

2 August 2017

15

1 reference

2 August 2017

657-75, viii

1 reference

2 August 2017

4

1 reference

Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Oligonucleotides as modulators of cancer gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Triplex formation inhibits HER-2/neu transcription in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Expression of HER2/erbB-2 correlates with survival in osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

p53-dependent cell death/apoptosis is required for a productive adenovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Viruses as oncolytic agents: a new age for "therapeutic" viruses?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Killing tumor cells with viruses--a question of specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

The role of the CD28 receptor during T cell responses to antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Oncogenic role of "master" transcription factors in human leukemias and sarcomas: a developmental model

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Conditionally replicating herpes vectors for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Ribozymes and the anti-gene therapy: how a catalytic RNA can be used to inhibit gene function.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Triple helix formation and the antigene strategy for sequence-specific control of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Chromosomal translocations in human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Gene fusions encoding chimaeric transcription factors in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

DNA replication of first-generation adenovirus vectors in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Antigen recognition by class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Proteolysis in MHC class II antigen presentation: who's in charge?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

The multistep nature of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970241-0

7 January 2021

10.1016/S0889-8588(05)70241-0

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11676278